… is an independent prognostic factor of poor OS and PFS in glioblastoma patients. With the
introduction of FET PET, we obtain a prognostic index that can help in glioblastoma treatment …

… FET PET-derived imaging parameters such as TBR and MTV provide valuable clinical
information on tumor response in GBM patients at … responders, FET PET parameters significantly …

In the treatment of patients suffering from malignant glioma, it is … like Positron emission
tomography (PET) and PET/CT which can … Here, too, PET/CT can facilitate in differentiating tumor …

… between MRI and FET PET target volumes is low and that FET PET target volumes are
considerably larger than MRI target volumes. Consequently, the integration of FET PET for target …

… )-l-tyrosine (FET) PET in Glioblastoma (FIG) trial is an Australian prospective, multi-centre
study evaluating FET PET for glioblastoma patient management. FET PET imaging timepoints …

… [15], FET–PET was suggested to be appropriate for accurate RT-planning [16], [17]. … 17
glioblastoma patients in whom CT/MRI based treatment planning was complemented by FET–PET…

… Following FET PET, all subjects had radiation and chemotherapy. Tumour ROIs were defined
… that FET PET probably has a prognostic value in patients with resected glioblastoma. The …

… patients with glioma, PET using the radiolabeled amino acid O-(2-[ 18 F]fluoroethyl)-L-tyrosine
(FET) … of amino acid PET for identifying treatment-related changes in patients with primary …

… FET-PET better delineates active GBM even more than 3 cm from the resection cavity (3).
Also, characteristic high 18 F-FET … increase accuracy of glioma definition, as FET-PET–based …

… PET using O-(2- 18 F-fluoroethyl)-l-tyrosine ( 18 F-FET) has been shown to be a useful tool
… patients with World Health Organization grade II–IV glioma who underwent 18 F-FET PET …